INDEPENDENT NEWS

Business, Regulatory and Patents Digest

Published: Mon 16 Feb 2004 05:26 PM
Business, Regulatory and Patents Digest
Cogitations: Business, Regulatory and Patents 16 February 2004 Guest Editorial - Business, Regulatory and Patents 16 February 2004 Research charity secures cancer gene patent EC to ask for GM corn approval German cabinet approves GM Bill Genesis result no cause for alarm, exec says Future bright for local drug industry, Professor says Relax rules on embryo use, scientists say
Cogitations: Business, Regulatory and Patents 16 February 2004 Last week the British medical charity, Cancer Research UK, announced it had secured the European patent on a gene that causes hereditary breast cancer. The patent covers all efforts to sequence the Stand up for your rights!Oops, they've done it again; our Government does not seem capable of presenting a consistent message, no matter the subject. On a current topical issue, we have Solici... More... http://www.BioSciNews.com/files/news-detail.asp?newsID=6246
Research charity secures cancer gene patent A British medical research charity announced Wednesday it has secured a Europe-wide patent on a key gene that causes hereditary breast cancer, saying it had won a victory that ensures that cancer rese... More... http://www.BioSciNews.com/files/news-detail.asp?newsID=6182
EC to ask for GM corn approval The European Commission on Wednesday will ask national governments to approve the sale of a gene-modified corn made by Monsanto Co., pressing ahead with efforts to lift the region's six-year ban on ne... More... http://www.BioSciNews.com/files/news-detail.asp?newsID=6201
German cabinet approves GM Bill German Chancellor Gerhard Schröder's cabinet on has approved a bill regulating the cultivation of genetically modified organisms. The bill would make it legal for German farmers and supermarkets to se... More... http://www.BioSciNews.com/files/news-detail.asp?newsID=6221
Genesis result no cause for alarm, exec says New Zealand's largest listed biotech company, Genesis Research, has enough cash to survive just two more years unless it can significantly reduce costs or boost revenue. The company has reported a... More... http://www.BioSciNews.com/files/news-detail.asp?newsID=6230
Future bright for local drug industry, Professor says University of Otago pharmacy school dean Professor Ian Tucker believes New Zealand's pharmaceutical industry can eventually achieve major international success. Professor Tucker was one of several... More... http://www.BioSciNews.com/files/news-detail.asp?newsID=6229
Relax rules on embryo use, scientists say New Zealand researchers want the right to destroy human embryos in order to grow stem cells that might one day provide cures for conditions such as Parkinson's disease. A lineup of scientists at t... More... http://www.BioSciNews.com/files/news-detail.asp?newsID=6237

Next in Business, Science, and Tech

Feds Applaud Fonterra On Bold Climate Change Announcement
By: Federated Farmers
Decision to Delay Monitoring ‘Fatally Flawed’
By: Maui and Hector's Dolphin Defenders
Kaikoura District Council – One year on
By: Kaikoura District Council
Fonterra Launches Plan to Improve Waterways
By: Fonterra
Targets good first step but Fonterra must reduce dairy herd
By: Greenpeace New Zealand
Our rivers need more than empty headlines from Fonterra
By: Greenpeace New Zealand
Fonterra pledges 13 more years of new coal boilers
By: Coal Action Network
Fonterra pledge will build on existing initiatives
By: Federated Farmers
Bioenergy Association congratulates Fonterra
By: Bioenergy Association
Greens Fail Dolphins
By: New Zealand National Party
Getting digital monitoring right
By: Seafood New Zealand
Kaikoura recovery by the numbers
By: Statistics New Zealand
Kaikōura Harbour back in business
By: New Zealand Government
View as: DESKTOP | MOBILEWe're in BETA! Send Feedback © Scoop Media